Deferasirox in mucormycosis: hopefully, not defeated
- PMID: 22167245
- DOI: 10.1093/jac/dkr529
Deferasirox in mucormycosis: hopefully, not defeated
Comment on
- 
  
  The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.J Antimicrob Chemother. 2012 Mar;67(3):715-22. doi: 10.1093/jac/dkr375. Epub 2011 Sep 20. J Antimicrob Chemother. 2012. PMID: 21937481 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
 
        